|
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ENSG00000114646 |
Summary for CSPG5 |
Gene summary |
| Gene information | Ensembl ID | ENSG00000114646 | Gene symbol | CSPG5 |
| Gene name | chondroitin sulfate proteoglycan 5 | |
| HGNC | 2467 | |
| Entrez ID | 10675 | |
| Gene type | protein_coding | |
| Synonyms | CSPG5|NGC | |
| UniProtAcc | O95196 |
Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for CSPG5 |
AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure.∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
Landscape of gene expressions across multiple cancer types. |
Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Top |
Sex-biased somatic mutation for CSPG5 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for CSPG5 |
Landscape of DNA methylation across multiple cancer types. |
Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| CHOL | cg15988232 | chr3:47579637 | CGI:chr3:47577622-47579641 | UTR,promoter,exon,gene body | 7.32e-01 | 6.14e-01 | 1.97e+00 | 4.84e-02 | 4.84e-02 | 1.19e-01 |
Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| THCA | cg15988232 | chr3:47579637 | CGI:chr3:47577622-47579641 | UTR,promoter,exon,gene body | 4.52e-01 | 3.24e-01 | 2.47e+00 | 1.34e-02 | 2.03e-02 | 1.28e-01 |
| HNSC | cg16233920 | chr3:47580307 | CGI:chr3:47577622-47579641 | UTR,promoter,exon,gene body | 7.57e-01 | 8.84e-01 | -4.28e+00 | 1.91e-05 | 6.48e-05 | -1.27e-01 |
| LUSC | cg01406312 | chr3:47579500 | CGI:chr3:47577622-47579641 | UTR,promoter,exon,gene body | 2.63e-01 | 1.58e-01 | 3.26e+00 | 1.10e-03 | 2.76e-03 | 1.05e-01 |
| LUSC | cg24899315 | chr3:47579529 | CGI:chr3:47577622-47579641 | UTR,promoter,exon,gene body | 3.27e-01 | 2.23e-01 | 2.60e+00 | 9.19e-03 | 1.30e-02 | 1.03e-01 |
| LUSC | cg04289624 | chr3:47579473 | CGI:chr3:47577622-47579641 | UTR,promoter,exon,gene body | 3.05e-01 | 1.73e-01 | 3.50e+00 | 4.58e-04 | 1.57e-03 | 1.32e-01 |
| LUSC | cg15988232 | chr3:47579637 | CGI:chr3:47577622-47579641 | UTR,promoter,exon,gene body | 5.53e-01 | 4.30e-01 | 2.75e+00 | 5.95e-03 | 9.30e-03 | 1.22e-01 |
| COAD | cg16233920 | chr3:47580307 | CGI:chr3:47577622-47579641 | UTR,promoter,exon,gene body | 7.03e-01 | 8.15e-01 | -2.45e+00 | 1.43e-02 | 1.90e-02 | -1.12e-01 |
| KIRP | cg04289624 | chr3:47579473 | CGI:chr3:47577622-47579641 | UTR,promoter,exon,gene body | 3.47e-01 | 2.20e-01 | 2.03e+00 | 4.21e-02 | 4.32e-02 | 1.27e-01 |
Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| HNSC | cg01406312 | chr3:47579500 | CGI:chr3:47577622-47579641 | UTR,promoter,exon,gene body | 3.23e-01 | 1.76e-01 | 2.78e+00 | 5.40e-03 | 1.38e-02 | 1.47e-01 |
| HNSC | cg15988232 | chr3:47579637 | CGI:chr3:47577622-47579641 | UTR,promoter,exon,gene body | 5.99e-01 | 4.85e-01 | 2.52e+00 | 1.17e-02 | 2.02e-02 | 1.13e-01 |
Top |
Exon skipping events with PSI in TCGA for CSPG5 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
Landscape of exon skipping events across multiple cancer types. |
Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for CSPG5 |
| ∗Please access CAeditome for RNA editing annotation. |
Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for CSPG5 |
TFs related to CSPG5.∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| ESCA | ZNF441 | CSPG5 | 3.75e+00 | 9.80e-01 | 2.65e+00 | 1.06e-03 | Male-biased |
| ESCA | ZNF792 | CSPG5 | 3.83e+00 | 9.81e-01 | 2.89e+00 | 2.66e-03 | Male-biased |
| PCPG | PLAGL2 | CSPG5 | 3.94e+00 | 9.81e-01 | 2.85e+00 | 2.56e-03 | Male-biased |
CSPG5 related gene.∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for CSPG5 |
RBPs related to ES in CSPG5.∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
CSPG5 related ES.∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs4955841 | chr3:55291709:C:T | - | 0.0914093299944898 | 2.27120109893314e-08 | LUAD | Female-baised eQTL |
| rs74399259 | chr3:55294115:A:G | - | 0.0874226120927473 | 8.19581126873898e-08 | LUAD | Female-baised eQTL |
| rs4955840 | chr3:55291577:T:C | - | 0.0824853675527615 | 2.54129181671308e-07 | LUAD | Female-baised eQTL |
| rs11130468 | chr3:55290285:C:T | - | 0.0795579861437669 | 6.12352375393866e-07 | LUAD | Female-baised eQTL |
| rs78646119 | chr3:55294249:A:G | - | 0.0792223676976113 | 7.27228440827416e-07 | LUAD | Female-baised eQTL |
| rs76791504 | chr3:55294256:T:C | - | 0.0792223676976113 | 7.27228440827416e-07 | LUAD | Female-baised eQTL |
| rs34006032 | chr3:40301022:G:A | - | 0.0710781146872052 | 4.80059466410902e-05 | LUAD | Female-baised eQTL |
| rs11541150 | chr3:40309786:C:T | - | 0.0710781146872052 | 4.80059466410902e-05 | LUAD | Female-baised eQTL |
| rs34385915 | chr3:40284512:C:T | - | 0.0707227741184097 | 5.56287214715997e-05 | LUAD | Female-baised eQTL |
| rs13085168 | chr3:40298941:A:G | - | 0.0682445534483413 | 9.64175301224808e-05 | LUAD | Female-baised eQTL |
| rs7649848 | chr3:40300220:C:A | - | 0.0682445534483413 | 9.64175301224808e-05 | LUAD | Female-baised eQTL |
| rs4130763 | chr3:40995981:T:C | - | 0.0539118009070642 | 0.00023479440557532 | LUAD | Female-baised eQTL |
| rs12631736 | chr3:55269942:G:C | - | 0.0553115041701868 | 0.000660638365546597 | LUAD | Female-baised eQTL |
| rs56414116 | chr3:55277054:G:A | - | 0.0498389303155213 | 0.000836524243880951 | LUAD | Female-baised eQTL |
| rs79816206 | chr3:55266747:G:A | - | 0.0540962549994181 | 0.000841625238962674 | LUAD | Female-baised eQTL |
| rs34856047 | chr3:40250345:C:T | - | 0.0583045666158941 | 0.000891942357966399 | LUAD | Female-baised eQTL |
| rs35981260 | chr3:40246726:G:A | - | 0.0582705552382144 | 0.000899729878165434 | LUAD | Female-baised eQTL |
| rs6801238 | chr3:55276616:T:C | - | 0.0489486281677928 | 0.000999357999668081 | LUAD | Female-baised eQTL |
| rs12494065 | chr3:38749991:C:T | - | 0.0536162019335446 | 0.00110070792773803 | LUAD | Female-baised eQTL |
| rs55830126 | chr3:55262388:C:G | - | 0.0473912101042293 | 0.00163066923727543 | LUAD | Female-baised eQTL |
| rs56824318 | chr3:38750575:T:G | - | 0.0503651069329888 | 0.00241580122325108 | LUAD | Female-baised eQTL |
| rs58410551 | chr3:38750979:A:G | - | 0.0503651069329888 | 0.00241580122325108 | LUAD | Female-baised eQTL |
| rs7630989 | chr3:38752449:A:G | - | 0.0503651069329888 | 0.00241580122325108 | LUAD | Female-baised eQTL |
| rs79252367 | chr3:55032686:G:T | - | 0.0403258116423485 | 0.0037379480023462 | LUAD | Female-baised eQTL |
| rs1256355 | chr3:41586098:A:G | - | -0.0487531813361801 | 0.00403206661590187 | LUAD | Female-baised eQTL |
| rs2700465 | chr3:41581447:C:A | - | -0.0475173455935468 | 0.00516617140069729 | LUAD | Female-baised eQTL |
| rs2576194 | chr3:41582521:T:C | - | -0.0474519500773691 | 0.0052769413185682 | LUAD | Female-baised eQTL |
| rs2132328 | chr3:41582627:T:C | - | -0.0474519500773691 | 0.0052769413185682 | LUAD | Female-baised eQTL |
| rs1256354 | chr3:41586686:T:G | - | -0.0474519500773691 | 0.0052769413185682 | LUAD | Female-baised eQTL |
| rs2526383 | chr3:50147105:T:C | - | -0.0382238841754511 | 0.00530364174824009 | LUAD | Female-baised eQTL |
| rs1874354 | chr3:41516236:A:T | - | -0.0474631879626156 | 0.00548729024358945 | LUAD | Female-baised eQTL |
| rs2643965 | chr3:41519854:A:G | - | -0.0474631879626156 | 0.00548729024358945 | LUAD | Female-baised eQTL |
| rs71331117 | chr3:40253300:G:A | - | 0.0499517743909426 | 0.00608846442784809 | LUAD | Female-baised eQTL |
| rs4955893 | chr3:54768324:A:G | - | 0.0450313097904656 | 0.00664727654194717 | LUAD | Female-baised eQTL |
| rs1691951 | chr3:41527167:T:C | - | -0.0460179926711743 | 0.00750178948439518 | LUAD | Female-baised eQTL |
| rs1691986 | chr3:41576929:A:C | - | -0.0452743367566191 | 0.00798057036832996 | LUAD | Female-baised eQTL |
| rs1273205 | chr3:41578403:G:T | - | -0.0452646917473948 | 0.00803271687279535 | LUAD | Female-baised eQTL |
| rs4928044 | chr3:54059637:C:T | - | 0.0469403289564188 | 0.00896430740241224 | LUAD | Female-baised eQTL |
| rs2643983 | chr3:41555864:T:A | - | -0.0427568663120608 | 0.00997159508162979 | LUAD | Female-baised eQTL |
| rs1565962 | chr3:41515498:A:G | - | -0.0423911016044722 | 0.0100556419538835 | LUAD | Female-baised eQTL |
| rs117581646 | chr3:57070742:T:C | - | 0.036683006997837 | 0.0113186625147922 | LUAD | Female-baised eQTL |
| rs11719697 | chr3:57071023:G:C | - | 0.036683006997837 | 0.0113186625147922 | LUAD | Female-baised eQTL |
| rs6797763 | chr3:38730078:T:C | - | 0.0426701958560787 | 0.0116814293448677 | LUAD | Female-baised eQTL |
| rs77679291 | chr3:57069096:T:C | - | 0.0367613632091493 | 0.0117340421127409 | LUAD | Female-baised eQTL |
| rs78227129 | chr3:57071785:A:G | - | 0.0367241729902838 | 0.0119453927519017 | LUAD | Female-baised eQTL |
| rs1691977 | chr3:41512799:G:A | - | -0.0413805722270088 | 0.0124233632133186 | LUAD | Female-baised eQTL |
| rs12636899 | chr3:57074523:C:A | - | 0.0373129012361706 | 0.0135354127112682 | LUAD | Female-baised eQTL |
| rs72866235 | chr3:38730492:A:G | - | 0.0410911175331026 | 0.0136440955801489 | LUAD | Female-baised eQTL |
| rs6783199 | chr3:57077611:T:A | - | -0.0369989431604367 | 0.0138762740513789 | LUAD | Female-baised eQTL |
| rs12639280 | chr3:41498561:C:T | - | -0.0416649784722014 | 0.0159227554605432 | LUAD | Female-baised eQTL |
| rs17081304 | chr3:41782940:T:C | - | 0.0411216419691312 | 0.0160990204594706 | LUAD | Female-baised eQTL |
| rs1989839 | chr3:50341515:A:G | - | 0.0354620499883106 | 0.016586347172014 | LUAD | Female-baised eQTL |
| rs6445852 | chr3:57088334:T:C | - | -0.0362677577030156 | 0.0166357203171697 | LUAD | Female-baised eQTL |
| rs9311641 | chr3:57091352:C:T | - | -0.0362677577030156 | 0.0166357203171697 | LUAD | Female-baised eQTL |
| rs72867808 | chr3:38758004:G:A | - | 0.0405315217581074 | 0.0167765494255565 | LUAD | Female-baised eQTL |
| rs9826171 | chr3:40250386:C:T | - | 0.0431735173221155 | 0.0170833086972164 | LUAD | Female-baised eQTL |
| rs57838764 | chr3:50337137:T:C | - | 0.0353149286072956 | 0.0176087669557022 | LUAD | Female-baised eQTL |
| rs11922599 | chr3:41557228:C:A | - | -0.0399109610106545 | 0.0176733213691002 | LUAD | Female-baised eQTL |
| rs7613493 | chr3:41488856:C:T | - | -0.0411837335903935 | 0.0177244354608339 | LUAD | Female-baised eQTL |
| rs4485691 | chr3:41561573:G:T | - | -0.0398835258111539 | 0.0178592141816525 | LUAD | Female-baised eQTL |
| rs7649874 | chr3:41562250:C:T | - | -0.0398835258111539 | 0.0178592141816525 | LUAD | Female-baised eQTL |
| rs903649 | chr3:41503454:G:A | - | -0.0396198272694187 | 0.0178937775259038 | LUAD | Female-baised eQTL |
| rs2055185 | chr3:41506866:C:T | - | -0.0396198272694187 | 0.0178937775259038 | LUAD | Female-baised eQTL |
| rs12496750 | chr3:38758692:G:A | - | 0.0398857138652785 | 0.0183268418238106 | LUAD | Female-baised eQTL |
| rs34270527 | chr3:54063198:A:T | - | 0.0419772288967586 | 0.0210235387703067 | LUAD | Female-baised eQTL |
| rs1495700 | chr3:41491378:C:A | - | -0.0402390344584627 | 0.021173126188676 | LUAD | Female-baised eQTL |
| rs80242482 | chr3:57068822:C:T | - | 0.0337528416657197 | 0.0211988528114128 | LUAD | Female-baised eQTL |
| rs71327066 | chr3:46444801:G:A | - | 0.0405096290105895 | 0.0212552306661209 | LUAD | Female-baised eQTL |
| rs6445857 | chr3:57113101:A:G | - | -0.0350859483618212 | 0.0229485267092262 | LUAD | Female-baised eQTL |
| rs7633611 | chr3:41493629:G:T | - | -0.0381749694836462 | 0.0229616408894051 | LUAD | Female-baised eQTL |
| rs9821613 | chr3:41558933:A:T | - | -0.0383615476227802 | 0.0234255494186212 | LUAD | Female-baised eQTL |
| rs62254321 | chr3:56515503:T:C | - | 0.0341005928276669 | 0.0237186970017277 | LUAD | Female-baised eQTL |
| rs11129941 | chr3:42138187:T:C | - | 0.0367456633584838 | 0.0239637978563859 | LUAD | Female-baised eQTL |
| rs7430731 | chr3:57120794:A:G | - | -0.034885077870317 | 0.0243066145572755 | LUAD | Female-baised eQTL |
| rs11923099 | chr3:40737129:C:G | - | 0.0409746247789693 | 0.0251095864901898 | LUAD | Female-baised eQTL |
| rs4575869 | chr3:41512178:C:G | - | -0.0375491415193426 | 0.0253987889195653 | LUAD | Female-baised eQTL |
| rs78138837 | chr3:50306747:A:G | - | 0.0331659030272069 | 0.0259789769893047 | LUAD | Female-baised eQTL |
| rs9814254 | chr3:57105397:T:C | - | -0.0343142266502518 | 0.0274986189641086 | LUAD | Female-baised eQTL |
| rs6808743 | chr3:57065778:T:C | - | 0.034429319539727 | 0.0280423759649134 | LUAD | Female-baised eQTL |
| rs60434489 | chr3:54058916:C:T | - | 0.0402021853058572 | 0.0281192333894461 | LUAD | Female-baised eQTL |
| rs11719296 | chr3:57083313:A:G | - | -0.03401012882168 | 0.0282210797640828 | LUAD | Female-baised eQTL |
| rs9874645 | chr3:57083488:A:G | - | -0.03401012882168 | 0.0282210797640828 | LUAD | Female-baised eQTL |
| rs1691952 | chr3:41490648:T:C | - | -0.0394184444002654 | 0.0294240741840755 | LUAD | Female-baised eQTL |
| rs75563240 | chr3:42113887:C:T | - | 0.0358141165070309 | 0.0298282093756307 | LUAD | Female-baised eQTL |
| rs11717604 | chr3:57069603:C:T | - | 0.0322129514191048 | 0.0301882774660674 | LUAD | Female-baised eQTL |
| rs2129821 | chr3:57101952:C:A | - | -0.0336338769406768 | 0.0322629174919761 | LUAD | Female-baised eQTL |
| rs12629572 | chr3:50287241:T:G | - | 0.0316041426765849 | 0.0327717776954732 | LUAD | Female-baised eQTL |
| rs35750877 | chr3:53065571:A:G | - | 0.0351092833340047 | 0.0353206016374577 | LUAD | Female-baised eQTL |
| rs35088929 | chr3:46446246:A:C | - | 0.0371248902387651 | 0.0359328251623538 | LUAD | Female-baised eQTL |
| rs1795317 | chr3:41490049:C:T | - | -0.0372478183934048 | 0.0373626371543326 | LUAD | Female-baised eQTL |
| rs9849674 | chr3:40256226:T:C | - | 0.0384223127521517 | 0.0377716853548043 | LUAD | Female-baised eQTL |
| rs12631455 | chr3:41498532:T:G | - | -0.0351814261423712 | 0.0378608076226979 | LUAD | Female-baised eQTL |
| rs11715513 | chr3:38708892:G:A | - | 0.0320288603123361 | 0.0401751666110132 | LUAD | Female-baised eQTL |
| rs34754279 | chr3:53065538:C:T | - | 0.0348406033090924 | 0.0403913842694367 | LUAD | Female-baised eQTL |
| rs80256390 | chr3:53065578:C:T | - | 0.0348406033090924 | 0.0403913842694367 | LUAD | Female-baised eQTL |
| rs74459344 | chr3:53065579:A:G | - | 0.0348406033090924 | 0.0403913842694367 | LUAD | Female-baised eQTL |
| rs71301811 | chr3:53065318:T:C | - | 0.0350204052787223 | 0.0405268298721788 | LUAD | Female-baised eQTL |
| rs9846606 | chr3:40435451:C:T | - | 0.0378109112556243 | 0.0426882441195843 | LUAD | Female-baised eQTL |
| rs1495695 | chr3:41488291:A:G | - | -0.0344749450057959 | 0.0452217580749216 | LUAD | Female-baised eQTL |
| rs7644787 | chr3:41776616:A:G | - | 0.0347776558064757 | 0.0455690703531719 | LUAD | Female-baised eQTL |
| rs7373160 | chr3:41492151:G:T | - | -0.034357097591805 | 0.0471362457114642 | LUAD | Female-baised eQTL |
| rs2230895 | chr3:46448875:G:A | - | 0.0352460426536831 | 0.0473474921281609 | LUAD | Female-baised eQTL |
Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs58645732 | chr3:42657983:C:T | - | 0.0820056889483873 | 0.00100247125819374 | LUAD | Male-baised eQTL |
| rs35384559 | chr3:42648017:T:C | - | 0.0795675425182756 | 0.00159837106975267 | LUAD | Male-baised eQTL |
| rs3733059 | chr3:42666621:C:T | - | 0.0795836297947053 | 0.0019701615669282 | LUAD | Male-baised eQTL |
| rs3733060 | chr3:42666623:A:T | - | 0.0795836297947053 | 0.0019701615669282 | LUAD | Male-baised eQTL |
| rs66933062 | chr3:42667226:C:T | - | 0.081164099097398 | 0.00242061284294267 | LUAD | Male-baised eQTL |
| rs13064597 | chr3:42661773:G:T | - | 0.0777118604200667 | 0.0026661830544114 | LUAD | Male-baised eQTL |
| rs13086680 | chr3:42670649:G:A | - | 0.0772318874077975 | 0.00309138540282551 | LUAD | Male-baised eQTL |
| rs34721465 | chr3:42672620:G:A | - | 0.0772125806813233 | 0.00372007249761756 | LUAD | Male-baised eQTL |
| rs3733061 | chr3:42666675:C:G | - | 0.0748713213914004 | 0.00388801138516668 | LUAD | Male-baised eQTL |
| rs67174294 | chr3:42661058:G:A | - | 0.0724762930535415 | 0.00514739280269429 | LUAD | Male-baised eQTL |
| rs67165547 | chr3:42660927:A:G | - | 0.0616265399778331 | 0.0117156143769586 | LUAD | Male-baised eQTL |
| rs2290976 | chr3:42667140:G:A | - | 0.0633017776048992 | 0.0121131424844355 | LUAD | Male-baised eQTL |
| rs1508209 | chr3:42462128:G:A | - | 0.0421773078899767 | 0.0293013469289327 | LUAD | Male-baised eQTL |
Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
| Gene ID: ENSG00000114646 | |
| CpG Site: cg07032164 | |
| Position to Gene: gene,exon,CDS,UTR | |
| Male Effect: - | |
| Female Effect: -0.0596249934276925 |
Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg07032164 | chr3:47577623 | gene,exon,CDS,UTR | -0.0596249934276925 | 7.18982283970557e-05 | -0.3241612560707379 | 1.1923308594680568e-07 | LUAD |
Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of CSPG5 |
Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
| ENSG00000114646 | CSPG5 | C0036341 | Schizophrenia | 2 | PSYGENET |